Therapeutic versus prophylactic bemiparin in hospitalized patients with nonsevere COVID-19 pneumonia (BEMICOP study): an open-label, multicenter, randomized, controlled trial - Marcos-Jubilar, M; Carmona-Torre, F; Vidal, R; BEMICOP Investigators (Thromb Haemost, 2022)